Navigation Links
Genomatica Delivers Pilot-Scale Validation in Sustainable Chemical Manufacturing
Date:6/29/2010

SAN DIEGO, June 29 /PRNewswire/ -- Genomatica announced today that it has achieved two key commercialization milestones ahead of schedule. First, the company achieved pilot-scale validation, at 3,000 liters, of the manufacturability and commercial viability of a 'green' version of 1,4-butanediol (BDO), its first commercial product. And second, the company confirmed the accelerated development time and reduced development and production costs made possible through use of its technology platform, from concept to commercialization.

(Photo:  http://photos.prnewswire.com/prnh/20100629/LA28088)

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100629/LA28088)

Pilot Validation for BDO Drives Readiness for Commercial Scale-up and Production

Genomatica's first planned commercial product is a 'green' BDO, made from renewable feedstocks rather than crude oil or natural gas. BDO, a product with a $3 billion and growing market, is used to make spandex, automotive plastics, running shoes and more.

Genomatica has completed multiple 3,000 liter batches of BDO using a variety of readily available commercial-grade sugars as feedstock. Yield, productivity, separation and purification were consistent with the targets required to produce Genomatica's green BDO at lower cost than typical commercial production of petroleum-based BDO.

The scale-up to 3,000 liters, a 100-fold increase from lab scale, was completed in two months. Results matched metrics from smaller-scale tests, and from Genomatica's modeling software. The scale-up was performed at MBI, a not-for-profit technology company affiliated with Michigan State University's BioEconomy Network, which has worked with companies including DuPont Applied BioSciences. "MBI's deep experience with scale-up and de-risking made them a great partner," said Mark Burk, chief technology officer of Genomatica.

Unique Development Platform Slashes Time to Market

Genomatica created and used its unique integrated bio-process engineering platform to develop its BDO organisms and complete manufacturing process. This was achieved in a record 2 1/2 years – dramatically faster than previous industry accomplishments with bio-processes.

Genomatica's platform allows high-throughput 'in-silico' (computer-based) design and testing of highly-optimized organisms, manufacturing processes and economics. This results in more efficient, focused lab work, much faster product development and time to commercial-scale manufacturing, lower-cost production, and de-risking of the process. Genomatica has applied to industrial biotech the same lessons of analysis, modeling and simulation that helped drive the realization of Moore's Law in the chip industry, rather than using more costly brute force or trial-and-error techniques.

The platform has also been proven through $20 million of partnerships with Dow, DSM, Unilever, NatureWorks/Cargill, Kyowa Hakko, and Verenium; and over 30 peer-reviewed projects funded by the National Institutes of Health, National Science Foundation, Department of Energy, Department of Defense and Environmental Protection Agency.

Significance to the Industry

"Genomatica's platform technology is the greatest enabling technology I've seen for industrial biotechnology – and I've seen a lot," said Bernhard Hauer, formerly BASF's vice president, research, and now professor at the University of Stuttgart. "This has the potential to catalyze a transformation of the chemical industry – no pun intended."

"The speed with which Genomatica introduced new generations of its 1,4-butanediol organism is impressive," said David Jones, Senior Vice President of MBI. "The company has set a new standard."

"By successfully implementing the manufacturing process at this scale, we have shown that our first product is ready for commercialization and that our platform delivers," said Mark Burk, chief technology officer of Genomatica. "Our bio-based BDO process will be cost-advantaged when compared to existing methods. We're looking forward to delivering these same advantages to additional products and processes."

About Genomatica

Genomatica is the emerging leader in the sustainable chemicals revolution. Genomatica aims to transform the chemical industry through clean, cheap, bio-based production of intermediate and basic chemicals – a $1 trillion plus market – from a range of current and next-generation renewable feedstocks rather than oil and gas. The company's unique integrated bio-process engineering platform allows 'in-silico' (computer-based) design and testing of highly-optimized organisms, manufacturing processes and economics. This results in much faster product development and time to commercial-scale manufacturing, and lower production costs. The platform has been proven in the record speed of pilot validation of Genomatica's first product, BDO; in partnerships with Dow, DSM, Unilever, NatureWorks/Cargill, Kyowa Hakko, and Verenium; and in over 30 peer-reviewed projects funded by the National Institutes of Health, National Science Foundation, Department of Energy, Department of Defense and Environmental Protection Agency. Genomatica has developed extensive intellectual property for clean, industrial biotechnology, including over 100 issued and pending patents, and IP on the pathways and/or strains for 20 of the top 100 intermediate and basic chemicals. Genomatica has raised $40 million from Alloy Ventures, Draper Fisher Jurvetson, Mohr Davidow Ventures and TPG Biotech.


'/>"/>
SOURCE Genomatica
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Genomatica Produces Pure BDO From Natural Sugars
2. New Genomatica Chemical Process Targets Ailing Ethanol Assets
3. invivodata Delivers Critical Symptom Relief Data in INSYS Therapeutics' Breakthrough Cancer Pain Trial
4. ECBC Delivers Mobile Labs to DRDC, Celebrates with Ribbon Cutting Ceremony
5. Intelligent Design Book Delivers Blow to Darwin
6. Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
7. Sparta Systems TrackWise(R) Solution Delivers Workforce Training and Learning Initiatives for Cangene Corporation
8. Zvetco Biometrics Delivers a Cohesive Security System Integrating Fingerprint Biometrics with Sun Identity Management Solutions.
9. Virtify, Inc. Delivers Industrys First Enterprise Content Compliance Software Suite for Life Sciences Companies
10. Caringo Delivers Storage Cluster in a Box with CAStor 3.0
11. Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
Breaking Biology Technology:
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):